Dysregulation of saliva and fecal microbiota as novel biomarkers of colorectal cancer
2024

Saliva and Fecal Microbiota as Biomarkers for Colorectal Cancer

Sample size: 361 publication 10 minutes Evidence: high

Author Information

Author(s): Rong Jiamei, Chen Xiaocui, Li Zhangqin, Li Bona, Sun Yang, Miao Yinglei

Primary Institution: First Affiliated Hospital of Kunming Medical University

Hypothesis

The study aims to investigate the biomarkers of salivary and fecal microbiota in colorectal cancer (CRC).

Conclusion

The study identified distinctive OTUs in saliva and feces that can help distinguish between healthy individuals, adenoma patients, and those with colorectal cancer.

Supporting Evidence

  • Analysis revealed higher bacterial diversity in saliva compared to feces.
  • Distinct differences in microbial communities were observed at both phylum and genus levels.
  • Seventeen core shared OTUs were identified across groups.

Takeaway

Doctors can look at the bacteria in your spit and poop to tell if you have colon cancer or not.

Methodology

The study used 16S rRNA high-throughput sequencing to analyze microbial diversity and species abundance in saliva and fecal samples from normal, adenoma, and CRC patients.

Potential Biases

The results may not be generalizable due to the specific population studied.

Limitations

The study may not fully represent the entire Yunnan region or the broader population due to the specific ethnic and dietary characteristics of the participants.

Participant Demographics

Participants included 122 normal samples, 122 adenoma samples, and 117 colorectal cancer samples, matched by age, gender, and body mass index.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fonc.2024.1498328

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication